115 related articles for article (PubMed ID: 9296100)
1. Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Richard G; Petit JC
Pathol Biol (Paris); 1997 May; 45(5):438-40. PubMed ID: 9296100
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].
Fremaux A; Sissia G; Geslin P
Pathol Biol (Paris); 1993 Sep; 41(7):636-40. PubMed ID: 8255615
[TBL] [Abstract][Full Text] [Related]
4. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
Knudsen JD
Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
[TBL] [Abstract][Full Text] [Related]
5. Killing kinetics of meropenem against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Richard G; Petit JC
J Antimicrob Chemother; 1996 Dec; 38(6):1085-9. PubMed ID: 9023658
[TBL] [Abstract][Full Text] [Related]
6. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
8. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
9. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
12. Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugs.
Lewis MT; Jones RN
Braz J Infect Dis; 2000 Feb; 4(1):15-21. PubMed ID: 10788841
[TBL] [Abstract][Full Text] [Related]
13. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
15. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
[TBL] [Abstract][Full Text] [Related]
17. Penicillin resistant Streptococcus pneumoniae isolates in Harare, Zimbabwe.
Simango C; Mvududu F
Cent Afr J Med; 1999 Apr; 45(4):100-2. PubMed ID: 10746390
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
Hernández M; Mejía GI; Trujillo H; Robledo J
Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
[TBL] [Abstract][Full Text] [Related]
19. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs].
Mihajlović-Ukropina M; Milutinović M
Med Pregl; 1998; 51(3-4):169-73. PubMed ID: 9611963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
